BRAINSTORM CELL THERAPEUTICS INC. 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Feb 28, 2017
Insider Transaction Report
Form 4
ARBEL IRIT
Director
Transactions
- Award
Stock Option (right to buy)
2017-02-26+6,667→ 6,667 totalExercise: $0.75From: 2017-02-26Exp: 2027-02-26→ Common Stock (6,667 underlying)
Holdings
- 153,333
Common Stock
Footnotes (2)
- [F1]Represents shares of Common Stock previously acquired and reported on Form 3 or Form 4. As of the date of this filing Reporting Person beneficially owns 153,333 shares of Common Stock of the Issuer.
- [F2]Option is fully vested and exercisable on the date of grant.